References
- FerlayJSoerjomataramIErvikMGLOBOCAN 2012 v10, cancer incidence and mortality worldwide: IARC CancerBase No. 11 (Internet)2013 Available from: http://globocan.iarc.frAccessed December 4, 2018
- Robert-Koch-Institut (Hrsg), Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg)Krebs in Deutschland für 2013/2014 [Cancer in Germany 2013/2014]Berlin2017
- BurgerMCattoJWDalbagniGEpidemiology and risk factors of urothelial bladder cancerEur Urol201363223424122877502
- Union internationale contre le cancer (UICC)TNM Classification of Malignant Tumours 8th Edition8th ed2017
- MostofiFSobinLTorloniHHistological Typing of Urinary Bladder TumoursGenevaWorld Health Organization1973
- BabjukMMBurgerMCompératEEAU Guidelines on Non-muscle-invasive Bladder Cancer: Limited Update 2017EAU Guidelines in Non-muscle-invasive Bladder cancer 20172018 Available from: https://uroweb.org/guideline/non-muscle-invasive-bladder-cancerAccessed December 4, 2018
- ShariatSFSfakianosJPDrollerMJKarakiewiczPIMerynSBochnerBHThe effect of age and gender on bladder cancer: a critical review of the literatureBJU Int2010105330030819912200
- ThorstensonAHagbergOLjungbergBGender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National Registry of Urinary Bladder CancerScand J Urol201650429229727002743
- NoonAPAlbertsenPCThomasFRosarioDJCattoJWCompeting mortality in patients diagnosed with bladder cancer: evidence of under-treatment in the elderly and female patientsBr J Cancer201310871534154023481180
- DonskyHCoyleSScosyrevEMessingEMSex differences in incidence and mortality of bladder and kidney cancers: national estimates from 49 countriesUrol Oncol20143212331
- SoaveADahlemRHansenJGender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohortEur J Surg Oncol201541336837724674298
- HenningAWehrbergerMMadersbacherSDo differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?BJU Int20131121687323320798
- HorstmannMWitthuhnRFalkMStenzlAGender-specific differences in bladder cancer: a retrospective analysisGend Med20085438539419108811
- RiekenMShariatSFKluthLComparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancerUrol Oncol20183618.e1718.e24
- XylinasEKentMKluthLAccuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladderBr J Cancer201310961460146623982601
- WalczakRBarKWalczakJThe value of EORTC risk tables in evaluating recurrent non–muscle–invasive bladder cancer in everyday practiceCent European J Urol2013664418422
- SylvesterRJvan der MeijdenAPOosterlinckWPredicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trialsEur Urol200649346647716442208
- MalmströmPUSylvesterRJCrawfordDEAn individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Gueŕin for non-muscle-invasive bladder cancerEur Urol200956224725619409692
- SolsonaEIborraIRicósJVMonrósJLCasanovaJDumontREffectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followupJ Urol199916141120112310081851
- PerlisNZlottaARBeyeneJFinelliAFleshnerNEKulkarniGSImmediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence reviewEur Urol201364342143023830475
- O’BrienTRayEChattertonKKhanMSChandraAThomasKProspective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancerBJU Int201311281096110424053153
- RinkMBabjukMCattoJWHexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literatureEur Urol201364462463823906669